Novo Nordisk A/S Statistics
Share Statistics
Novo Nordisk A/S has 4.54B shares outstanding. The number of shares has increased by 1.31% in one year.
| Shares Outstanding | 4.54B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 2.94% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 4.53B |
| Failed to Deliver (FTD) Shares | 469.49K |
| FTD / Avg. Volume | 6.99% |
Short Selling Information
The latest short interest is 4.70M, so 0.1% of the outstanding shares have been sold short.
| Short Interest | 4.70M |
| Short % of Shares Out | 0.1% |
| Short % of Float | 0.1% |
| Short Ratio (days to cover) | 0.87 |
Valuation Ratios
The PE ratio is 37.4 and the forward PE ratio is 26.3. Novo Nordisk A/S's PEG ratio is 0.13.
| PE Ratio | 37.4 |
| Forward PE | 26.3 |
| PS Ratio | 13.47 |
| Forward PS | 0.9 |
| PB Ratio | 29.37 |
| P/FCF Ratio | 44.7 |
| PEG Ratio | 0.13 |
Enterprise Valuation
Novo Nordisk A/S has an Enterprise Value (EV) of 3,143.90B.
| EV / Earnings | 37.57 |
| EV / Sales | 13.54 |
| EV / EBITDA | 27.74 |
| EV / EBIT | 30.65 |
| EV / FCF | 44.9 |
Financial Position
The company has a current ratio of 0.82, with a Debt / Equity ratio of 0.2.
| Current Ratio | 0.82 |
| Quick Ratio | 0.64 |
| Debt / Equity | 0.2 |
| Total Debt / Capitalization | 16.65 |
| Cash Flow / Debt | 5.12 |
| Interest Coverage | 138.8 |
Financial Efficiency
Return on equity (ROE) is 0.79% and return on capital (ROIC) is 61.4%.
| Return on Equity (ROE) | 0.79% |
| Return on Assets (ROA) | 0.27% |
| Return on Capital (ROIC) | 61.4% |
| Revenue Per Employee | 3.23M |
| Profits Per Employee | 1.16M |
| Employee Count | 71.88K |
| Asset Turnover | 0.74 |
| Inventory Turnover | 1.12 |
Taxes
| Income Tax | 20.99B |
| Effective Tax Rate | 0.2 |
Stock Price Statistics
The stock price has increased by -23.64% in the last 52 weeks. The beta is 0.17, so Novo Nordisk A/S's price volatility has been higher than the market average.
| Beta | 0.17 |
| 52-Week Price Change | -23.64% |
| 50-Day Moving Average | 100.83 |
| 200-Day Moving Average | 123.07 |
| Relative Strength Index (RSI) | 27.42 |
| Average Volume (20 Days) | 6.71M |
Income Statement
In the last 12 months, Novo Nordisk A/S had revenue of 232.26B and earned 83.68B in profits. Earnings per share was 9.34.
| Revenue | 232.26B |
| Gross Profit | 196.50B |
| Operating Income | 102.57B |
| Net Income | 83.68B |
| EBITDA | 113.33B |
| EBIT | 102.57B |
| Earnings Per Share (EPS) | 9.34 |
Balance Sheet
The company has 14.39B in cash and 27.01B in debt, giving a net cash position of -12.61B.
| Cash & Cash Equivalents | 14.39B |
| Total Debt | 27.01B |
| Net Cash | -12.61B |
| Retained Earnings | 104.84B |
| Total Assets | 397.44B |
| Working Capital | -13.20B |
Cash Flow
In the last 12 months, operating cash flow was 108.91B and capital expenditures -38.90B, giving a free cash flow of 70.01B.
| Operating Cash Flow | 108.91B |
| Capital Expenditures | -38.90B |
| Free Cash Flow | 70.01B |
| FCF Per Share | 15.62 |
Margins
Gross margin is 84.6%, with operating and profit margins of 44.16% and 36.03%.
| Gross Margin | 84.6% |
| Operating Margin | 44.16% |
| Pretax Margin | 45.07% |
| Profit Margin | 36.03% |
| EBITDA Margin | 48.79% |
| EBIT Margin | 44.16% |
| FCF Margin | 30.14% |
Dividends & Yields
NVO pays an annual dividend of $1.03, which amounts to a dividend yield of 1.22%.
| Dividend Per Share | $1.03 |
| Dividend Yield | 1.22% |
| Dividend Growth (YoY) | 16.52% |
| Payout Ratio | 35.27% |
| Earnings Yield | 11.5% |
| FCF Yield | 19.01% |
Analyst Forecast
The average price target for NVO is $140, which is 72.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $140 |
| Price Target Difference | 72.4% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
Stock Splits
The last stock split was on Sep 20, 2023. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 20, 2023 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 2.92 |
| Piotroski F-Score | 7 |